Oligonucleotides, Oxycodone And Osteoarthritis Among 49 US FDA Guidances
A Number Of Oncology Drugs Also Among Raft Of Product Specific Guidances
The FDA has seemingly followed the lead of the EMA by guiding ANDA sponsors on how to develop oligonucleotide drugs, a complex class of DNA or RNA molecules.
